Solo-Dex, Inc. Strikes Groundbreaking Master Distributor Agreement with CH Trading Group LLC and Farouk, Maamoun Tamer & Co. for the Distribution of its Fascile(R) Non-Opioid Acute Pain Management Suite in the Kingdom of Saudi Arabia

WOLF CREEK, MT / ACCESSWIRE / July 26, 2023 / Solo-Dex, a leading player in the development, manufacture, and sales of innovative non-opioid acute pain management solutions, is pleased to announce a strategic master distribution agreement with CH Trading Group LLC and Farouk, Maamoun Tamer & Co. This groundbreaking partnership will pave the way for the distribution of Solo-Dex’s revolutionary Fascile® suite of products within the Kingdom of Saudi Arabia.

CH Trading Group will spearhead the continued commercialization of Solo-Dex Fascile® products across the Middle East and North Africa markets, with opportunities to broaden distribution across the wider Islamic world. This alliance also holds potential for further expansion to encompass other solutions within Solo-Dex’s non-opioid pain portfolio.

Solo-Dex Fascile® products serve to manage acute pain during pre-surgical, intra-surgical, and post-surgical phases without the use of opioids. These cutting-edge products can be placed by a single professional in mere minutes and are designed to stay intact throughout recovery. By implementing the Fascile® suite, Solo-Dex aims to redefine post-surgical acute pain control, prioritizing patient safety, facilitating improved recovery, and providing a solution that is easily implementable in a home setting.

Dr. Yasser Khattab, CEO of Tamer Healthcare, expressed his enthusiasm for the partnership, “We are proud to partner with Solo-Dex to bring the people of KSA a non-opioid alternative for pain management, without the risks associated with opioid addiction.” Dr. Ahmed Mousa, Business Development Head at Tamer Healthcare, added, “We are eager to provide our patients with full access to Solo-Dex products.” Steven Eror, Solo-Dex CEO, views this agreement as a significant stride towards the company’s mission to bring opioid-free acute pain management to hospitals and surgical centers worldwide.

About Solo-Dex

Solo-Dex is a trailblazing company, generating revenue through the acquisition, development, and commercialization of non-opioid pain management solutions for the treatment of acute and chronic pain. Solo-Dex is unwavering in its commitment to becoming the global leader in pain management, dedicated to social, environmental, economic, and ethical principles in the responsible development of pharmaceutical products to enhance the quality of life.

About CH Trading Group

CH Trading Group LLC (“CH Trading Group”) is part of the CH Group family of companies ( CH Trading Group constitutes a diversified conglomerate targeting eight economic” Sectors”: healthcare, pharmaceuticals, food, finance, cosmetics, tourism, fashion, media/entertainment. Spanning a variety of multi-national products, services and solutions, its world mission involves connecting, developing, and promoting, from Local to Global™ and throughout the world, all aspects of a wholesome, healthy, and productive lifestyle.

CH Trading focuses on international import/export and trade, prioritizing the countries of the Organization of Islamic Cooperation (OIC), as well as the Middle East and North Africa (MENA) and Gulf Cooperation Council (GCC) Regions. It has responded to worldwide demands for identifying and securing supply chains by introducing innovative products, including those from the US, and developing a robust distribution network for goods.

About Farouk, Maamoun Tamer & Co.

Founded in 1922, Tamer Group is a leading healthcare and wellness group serving the Kingdom of Saudi Arabia, the Middle East, and the North African region. The source of the Group’s resilience lies in the decision to consistently operate from its core purpose, creating shared value and fostering progress for people within the organization, communities, the Kingdom of Saudi Arabia, and beyond. Tamer’s success is also due to the positive regulatory climate of the Kingdom and the ambitious and transformative socio-economic project of Vision 2030.

For more information, please visit:

For more information or inquiries, please contact:

Investors and Media
Solo-Dex, Inc.
1576 MT Highway 434
Wolf Creek, MT 59648
Office: (801) 631-7288

SOURCE: Solo-Dex, Inc.

Previous Post
Newer Post